Sanjeeva Kalva
Associate Professor
Radiology
UT Southwestern Medical Center
United States of America
Biography
Sanjeeva Kalva, M.D., grew up in South India. He was drawn to medicine, he recalls, “as an opportunity to serve other people at a very close level.” He trained there in interventional radiology (IR), then spent four years on faculty at Kovai Medical Center and Hospital, Coimbatore, India, where he performed wide-ranging vascular interventional procedures. “Interventional radiology is a very exciting field,” says Dr. Kalva. “You can achieve a lot of good results with very minimally invasive procedures. That attracted me quite a bit.” In 2003, Dr. Kalva joined the Harvard Medical School as a researcher, studying abdominal interventions at Massachusetts General Hospital. He then did an IR fellowship there, and after completion he was recruited at once to the Harvard faculty. Dr. Kalva spent a decade at Harvard caring for patients, teaching, and conducting cutting-edge research in IR before joining the UT Southwestern faculty as Chief of Interventional Radiology in 2013. In addition to leading multiple research studies and publishing book chapters, a book, and many peer-reviewed papers, he has helped establish standards of care for his peers in the field, including the use of inferior vena cava filters and the management of aortic disease. He is actively involved in education, teaching IR to medical students, residents, and fellows and offering interdisciplinary lectures to physicians whose specialties overlap with IR.
Research Interest
Liver Cancer, Chemoembolization, Radioembolization, Ablation Portal Hypertension, Transjugular Intrahepatic Portosystemic Shunt, Balloon-occluded Retrograde Trasnsvenous Obliteration of varices Pulmonary Vascular Diseases: Arteriovenous malformation, Thromboembolism Varicose veins, Chronic Venous insufficiency, Venous hypertension, Endovenous Laser Ablation, Sclerotherapy, Phlebectomy Venous thromboembolism, Vena Cava Filters, Venous thrombolysis
Publications
-
Tumor Enhancement and Heterogeneity Are Associated With Treatment Response to Drug-Eluting Bead Chemoembolization for Hepatocellular Carcinoma. Reis SP, Sutphin PD, Singal AG, Grzybowski R, Fisher S, Ball C, Xi Y, Grewal S, Kalva SP J Comput Assist Tomogr 2016 Nov
-
Predicting Outcomes After Chemo-Embolization in Patients with Advanced-Stage Hepatocellular Carcinoma: An Evaluation of Different Radiologic Response Criteria. Gunn AJ, Sheth RA, Luber B, Huynh MH, Rachamreddy NR, Kalva SP Cardiovasc Intervent Radiol 2016 Nov
-
Single-Center Comparison of Overall Survival and Toxicities in Patients with Infiltrative Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization or Drug-Eluting Embolic Transarterial Chemoembolization. McDevitt JL, Alian A, Kapoor B, Bennett S, Gill A, Levitin A, Sands M, Narayanan Menon KV, Aucejo FN, Estfan B, Pillai AK, Kalva SP, McLennan G J Vasc Interv Radiol 2017 Jul